(2E)-1-(2,5-dichlorophenyl)-3-(3-methylphenyl)prop-2-en-1-one, 95.0%, 2g

1-[4-(DIPHENYLMETHYL)-1-PIPERAZINYL]-3,3-DIPHENYL-1-PROPANONE, 95%, 500mg

1H-Pyrrolo[3,2-H]quinoline, 95.0%, 1g

2-Fluoro-5-nitropyridine, 99.00%, 100g

5-amino-2-[(tetrahydro-2-furanylmethyl)amino]benzoic acid, 95.0%, 5g

4-(4-Benzylphenyl)-1,3-thiazol-2-amine, 95.0%, 250mg

1-(3-methylbutyl)-4-nitro-1H-pyrazole, 95.0%, 250mg

Plan PLPHi S100x/1.25 phase contrast IOS infinity corrected lens

5-Fluoro-1H-indole-2-carbaldehyde, 95.0%, 250mg

(S)-2-Amino-3-(6-chloro-1H-indol-3-yl)propanoic acid, 95.0%, 5g

Diethyl (4-(5-oxido-10H-phenothiazin-10-yl)butyl)phosphonate, 97%, 1g

Ethyl 2-(5-amino-2-bromo-4-fluorophenyl)acetate, 98%, 1g

(R)-(-)-2,2-Dimethyl-1,3-dioxolane-4-ylmethyl p-toluenesulfonate, 95.0%, 10g